Author Question: An individual with a body mass of _____ receives the maximum number of points for BMI in the Mini ... (Read 14 times)

casperchen82

  • Hero Member
  • *****
  • Posts: 540
An individual with a body mass of _____ receives the maximum number of points for BMI in the Mini Nutritional Assessment.
 a. less than 19 b. 19 to 21
  c. 21 to 22 d. 23 or higher

Question 2

After you and your friend Dolores share pretzels and animal crackers, she announces that she wants to start digesting her food by watching television. You inform Dolores that
 a. she really should spend 10-15 minutes on the treadmill to help her body break down the carbohydrates faster.
  b. her body will not begin to break down the carbohydrates for a couple more hours until they reach the small intestine.
  c. the hydrochloric acid in her stomach breaks down all the carbohydrates and she need not rest while this occurs.
  d. carbohydrate digestion begins in the mouth through the action of amylase, so she has already begun digesting the snacks.



Jane

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library